港股異動 | 醫療器械股下挫 冠脈支架帶量採購開展
格隆匯10月19日丨醫療器械股下挫,港股市場微創醫療一度下挫逾11%,現跌8.26%;A股市場普樂醫療跌近7%。國家組織高值醫用耗材聯合採購辦公室發表10月16日《國家組織冠脈支架集中帶量採購檔》,由天津市醫藥採購中心承擔聯合量採購辦公室日常工作,向相關企業發起談判邀請。首年意向採購總量為107.47萬個,參考價2850元人民幣,此前,冠脈支架市場中,其中國產支架約9000元至1.1萬元人民幣,進口支架約1.5萬元至1.9萬元人民幣。全國性的高值耗材集採可能直接讓冠脈支架進入千元級時代。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.